NCT03756649
Mayo Clinic IBD Biobank
Enrolling by Invitation
Not specifiedAges 18–85ObservationalMayo ClinicInvestigator-initiated
~1,000 participants
Updated 2026-02-17 on ClinicalTrials.gov
What's tested:Blood DrawUrine CollectionStool Collection
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Study Participants
Measured over 50 years
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Konstantinos N. Lazaridis, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients diagnosed with inflammatory bowel disease (IBD) who are between the ages of 18 and 85 at time of study enrollment.
The diagnosis of IBD will be based on the standard IBD criteria including biochemical and colonoscopy screening.
Women with inflammatory bowel disease of childbearing potential and pregnant women will be offered enrollment because there is no risk to an unborn child in this investigation.
Patients between the ages of 18 and 85 without history of IBD or colon cancer.
Exclusion
Patients with known liver disease.
Patients unable to provide informed consent.
Prisoners and institutionalized individuals.
Patients with a history of colorectal cancer.
What this trial measures
- Study Participants50 years
Total number of participants in the study